MEETING ON THIMEROSAL-CONTAINING VACCINES

Registration for the public session of the Institute of Medicine’s Immunization Safety Review meeting on thimerosal-containing vaccines and neurodevelopmental outcomes on July 16, 200 is now CLOSED. The meeting room has reached its maximum capacity, and only those registrants who have received confirmation as of today via email will be admitted into the Conant Wadsworth B Conference Room at the Charles Hotel on July 16, 2001. For those who are unable to attend the meeting, please note that an audio version of the entire meeting and a copy of the slide presentations will be posted on our website (www.iom.edu/imsafety) within two weeks after the meeting.

For your information the agenda for the open scientific workshop to be held on July 16 in Cambridge, MA has been posted at www.iom.edu/imsafety. In addition, a list of materials sent to the committee to date will be posted later this week at www.iom.edu/imsafety.

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.